Adverse reactions during rifampicin treatment.
D000937:Antigen-Antibody Reactions; D001663:Bilirubin / Q000378:metabolism; D004342:Drug Hypersensitivity; D006801:Humans; D008099:Liver / Q000187:drug effects; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors; D000637:Transaminases / Q000097:blood; D014376:Tuberculosis / Q000188:drug therapy* / Q000201:enzymology
D000637:Transaminases; D001663:Bilirubin; D012293:Rifampin